Drugs / DF2755A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04803396 | Nov 2018 → Jun 2019 | — | Dompé Farmaceutici S.p.A | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DF2755A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04803396 ↗ |
| Action | Inhibit | “allosteric inhibitor of CXCR1/2” NCT04803396 ↗ |
| Route | Oral | “Single oral dose administration on D1” NCT04803396 ↗ |
| Target | CXCR1 | “allosteric inhibitor of CXCR1/2” NCT04803396 ↗ |